共 50 条
- [1] Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02): : 144 - 145
- [2] Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. Reply NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02): : 146 - 146
- [3] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (04): : 305 - 305
- [5] IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER JOURNAL OF IMAB, 2008, 14 (01): : 48 - 50
- [7] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23): : 2335 - 2342
- [8] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13): : 905 - 914
- [9] Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer ONCOLOGY-NEW YORK, 2000, 14 (12): : 51 - 55
- [10] Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: A new survival standard ONCOLOGIST, 2001, 6 (01): : 81 - 91